Adverse drug reactions in older people: Detection and prevention

Drugs and Aging

Volumn 29, Issue 6, 2012, Pages 453-462

  Petrovic, Mirko ^a   Van Der Cammen, Tischa ^b   Onder, Graziano ^c  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Adverse drug reactions; Elderly; Prescribing

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; DIGOXIN; HYPNOTIC AGENT; PENICILLIN G; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADVERSE DRUG REACTION; AGED; AGING; ANTICHOLINERGIC EFFECT; CLINICAL PHARMACY; DIGITALIS INTOXICATION; EDUCATION; ELECTRONIC PRESCRIBING; GERIATRIC CARE; HEALTH CARE; HOSPITAL CARE; HUMAN; MORBIDITY; MORTALITY; PATIENT CARE; PENICILLIN ALLERGY; PHARMACODYNAMICS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SEROTONIN SYNDROME;

AGED; DRUG TOXICITY; HUMANS; RESEARCH DESIGN; RISK FACTORS;

EID: 84861656809     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11631760-000000000-00000     Document Type: Review

References (66)

1. World Health Organization. International drug monitoring: The role of the hospital. World Health Organ Tech Rep 1969; 425: 5-24
2. Mannesse C, Derkx F, De Ridder M, et al. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing 2000; 29: 35-39
3. Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalized patients: A meta-Analysis of prospective studies. JAMA 1998; 279: 1200-5
4. Cresswell K, Fernando B, McKinstry B, et al. Adverse drug events in the elderly. Br Med Bull 2007; 83: 259-274
5. Somers A, Petrovic M, Robays H, et al. Reporting adverse drug reactions on a geriatric ward: A pilot project. Eur J Clin Pharmacol 2003; 58: 707-714
6. Routledge P, O'Mahony M, Woodhouse K. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2003; 57: 121-126
7. O'Mahony MS, Woodhouse KW. Age, environmental factors and drug metabolism. Pharmacol Ther 1994; 61: 279-287
8. Turnheim K. When drug therapy gets old: Pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003; 38: 843-853
9. Leendertse A, Egberts A, Stoker L, et al., HARM Study Group. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168: 1890-6
10. Beijer H, De Blaey C. Hospitalisations caused by adverse drug reactions (ADR): A meta-Analysis of observational studies. Pharm World Sci 2002; 24: 46-54
11. Gray S, Sager M, Lestico M, et al. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1998; 53: M59-63
12. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004; 329: 15-19
13. Ray W, Griffin M, Shorr R. Adverse drug reactions and the elderly. Health Affairs 1990; 9: 114-122
14. Rawlins M, Thompson J. Pathogenesis of adverse drug reactions. In: Davies D, editor. Textbook of adverse drug reactions. 2nd ed. Oxford: Oxford University Press, 1981: 11
15. Edwards R, Aronson J. Adverse drug reactions: Definitions, diagnosis, and management. Lancet 2000; 356: 1255-9
16. Wang L. Epidemiology and prevention of adverse drug reactions in the elderly. J Geriatr Cardiol 2005; 2: 248-253
17. Rawlins M, Thompson J. Pathogenesis of adverse drug reactions. In: Davies D, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press, 1977: 44
18. Aronson J. Adverse drug reactions: No farewell to harms. Br J Clin Pharmacol 2007; 63: 131-135
19. Laroche ML, Charmes JP, Marcheix A, et al. Problems encountered with the evaluation of renal function in the elderly in order to adjust drug administration. Pharmacotherapy 2006; 26: 1041-6
20. Page R, Linnebur S, Bryant L, et al. Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions. Clin Interv Aging 2010; 5: 75-87
21. Kinirons MT, Crome P. Clinical pharmacokinetic considerations in the elderly: An update. Clin Pharmacokinet 1997; 33: 302-312
22. Mayersohn M. Pharmacokinetics in the Elderly. Environ Health Perspect 1994; 102 Suppl. 11: 119-124
23. Klotz U, Avant G, Hoyumpa A, et al. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 1975; 55: 347-359
24. Swift C. Pharmacodynamics: Changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly. Br Med Bull 1990; 40: 36-52
25. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991; 114: 956-966
26. Stewart R, Cooper J. Polypharmacy in the aged. Practical solutions. Drugs Aging 1994; 4: 449-461
27. Hajjar E, Cafiero A, Hanlon J. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 314-6
28. Goldberg R, Mabee J, Chan L, et al. Drug-drug and drugdisease interactions in the ED: Analysis of a high-risk population. Am J Emerg Med 1996; 14: 447-450
29. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-5
30. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: What doctors believe and patients actually do. Br J Clin Pharmacol 2001; 51: 615-622
31. Lindley C, Tully M, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294-300
32. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: A population-based study of the very old. Drugs Aging 2005; 22: 69-82
33. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med 1991; 151: 1825-1832
34. Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol 2000; 7: 103-7
35. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): Application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008; 37: 673-9
36. Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol 1992; 45: 1045-1051
37. Rochon P, Gurwitz J. Optimising drug treatment for elderly people: The prescribing cascade. BMJ 1997; 315: 1096-9
38. Woolcott J, Richardson K, Wiens M, et al. Meta-Analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169: 1952-1960
39. Agbabiaka TB, Savovic J, Ernst E. Methods for causality assessment of adverse drug reactions: A systematic review. Drug Saf 2008; 31: 21-37
40. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
41. World Health Organization-Uppsala Monitoring Centre (WHO-UMC). The use of the WHO-UMC system for standardised case causality assessment. Uppsala: The Uppsala Monitoring Centre [online]. Available from URL: Http://who-umc.org/ Graphics/24734.pdf [Accessed 2012 Mar 19]
42. Shenfield G, Robb T, Duguid M. Recording previous adverse drug reactions: A gap in the system. Br J Clin Pharmacol 2001; 5: 623-6
43. Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc 2002; 50: 1962-8
44. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: How well can it be measured and optimised? Lancet 2007; 370: 173-184
45. Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR Risk Score. Arch Intern Med 2010; 170: 1142-8
46. Gurwitz J, Field T, Harrold L, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1116
47. Field T, Gurwitz J, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161: 1629-1634
48. Onder G, Landi F, Della Vedova C, et al.; GIFA Study. Moderate alcohol consumption and adverse drug reactions among older adults. Pharmacoepidemiol Drug Saf 2002; 1: 385-392
49. Bates D, Miller E, Cullen D, et al., ADE Prevention Study Group. Patient risk factors for adverse drug events in hospitalized patients. Arch Intern Med 1999; 159: 2553-2560
50. Gurwitz JH, Rochon P. Improving the quality of medication use in elderly patients: A not-so-simple prescription. Arch Intern Med 2002; 162: 1670-2
51. McDowell S, Coleman J, Ferner R. Systematic review and meta-Analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006; 332: 1177-1181
52. Zeeh J, Platt D. The aging liver: Structural and functional changes and their consequences for drug treatment in old age. Gerontology 2002; 48: 121-7
53. Catananti C, Liperoti R, Settanni S, et al. Heart failure and adverse drug reactions among hospitalized older adults. Clin Pharmacol Ther 2009; 86: 307-310
54. Routledge P, O'Mahony M, Woodhouse K. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57: 121-6
55. Laroche M, Charmes J, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2006; 63: 177-186
56. Laroche M, Charmes J, Marcheix A, et al. Estimation of glomerular filtration rate in the elderly: Cockcroft-Gault formula versus modification of diet in renal disease formula. Pharmacotherapy 2006; 26: 1041-6
57. Merle L, Laroche M, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005; 22: 375-392
58. Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: A randomized controlled trial. Arch Intern Med 2009; 169: 894-900
59. Somers A, Robays H, Vander Stichele R, et al. Contribution of drug related problems to hospital admission in the elderly. J Nutr Health Aging 2010; 14: 477-482
60. Fusco D, Lattanzio F, Tosato M, et al. Development of CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project: Rationale and methodology. Drugs Aging 2009; 26 Suppl. 1: 3-13
61. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 2005; 294: 716-724
62. Abellan Van Kan G, Rolland Y, Houles M, et al. The assessment of frailty in older adults. Clin Geriatr Med 2010; 26: 275-286
63. Ellis G, Whitehead MA, O'Neill D, et al. Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev 2011; 7: CD006211
64. Onder G, Lattanzio F, Battaglia M, et al. The risk of adverse drug reactions in older patients: Beyond drug metabolism. Curr Drug Metab 2011; 12: 647-651
65. Lampela P, Hartikainen S, Lavikainen P, et al. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: A population-based intervention study. Drugs Aging 2010; 27: 507-521
66. Schmader KE, Hanlon JT, Pieper CF, et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004; 116: 394-401